Home > Press > AOAC Awards Approval to FoodChek(TM)-E. coli O157 Test for 375g Sample
Abstract:
FoodChek Systems Inc. ("FoodChek") (formerly Vacci-Test Corporation) is pleased to announce that the AOAC Research Institute, the approval body for all U.S. food safety tests, has approved a modification to its existing FoodChek™-E. coli O157 test for a 25g sample to that of the industry-standard sample size of 375g for detecting E. coli O157 in raw ground beef. This extended AOAC approval also includes the 65g and 325g composited sample sizes.
FoodChek™-E. coli O157 continues to demonstrate superior sensitivity to the USDA's zero-tolerance requirement by detecting 1 colony-forming unit in a 375g sample of ground beef. With the larger 375g sample size, FoodChek has once again proven that its test is fast and accurate, yet simple and cost-effective for detecting E. coli O157 in less than 8 hours (including enrichment time).
William J. Hogan, President & CEO, stated "The AOAC's 375g ground beef sample approval for FoodChek™-E. coli O157 provides meat processors significant operational benefits including the ability to improve on 'Process Control' issues and allow same-shift product release, thereby eliminating expensive holding costs. The superior speed and accuracy of our E. coli O157 test will enable meat processors to achieve their goal of detecting the pathogen in raw material and finished products, if it is there."
This information release may contain certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its private filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
####
About FoodChek
FoodChek specializes in the development of advanced state of the art food safety testing. FoodChek utilizes its revolutionary proprietary magnetic nanotechnology for the fast, accurate and simple yet cost-effective detection of food-borne pathogens. FoodChek™-E. coli O157 is an AOAC-approved Performance Tested Method (Certificate #060902).
About AOAC
The AOAC Research Institute, a subsidiary of AOAC International (www.aoac.org), is an independent non-profit corporation whose stated purpose is to promote and carry out activities related to the development, improvement, and understanding of analytical practices and procedures affecting public health and welfare.
For more information, please click here
Contacts:
FoodChek Systems Inc.
William J. Hogan
President & CEO
(403) 269-9424
FoodChek Systems Inc.
Suite 450, 1414 - 8th Street S.W.
Calgary, Alberta, Canada T2R 1J6
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Food/Agriculture/Supplements
Silver nanoparticles: guaranteeing antimicrobial safe-tea November 17th, 2023
Night-time radiative warming using the atmosphere November 17th, 2023
DGIST and New Life Group launched a research project on "Functional beauty and health products using the latest nanotechnology" May 12th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||